PD-1 and PD-L1 Inhibitors 2020 Analysis for PD-1 and PD-L1 Inhibitors | Page 3

Scope
• Overview of PD-1 and PD-L1 inhibitors, role, significance, pathway, mechanism
of action (MoA) and biomarkers of PD-1 and PD-L1 inhibitors
• The new report has covered the worldwide market of PD-1 and PD-L1
inhibitors, information of marketed molecules including along with patent expiry
and impact on market after expiry and detail profiling of Pipeline assets
• It also includes Indication wise detailed epidemiology along with trends in
epidemiology, incidence and prevalence segmented in to major geographies
• Key topics covered include strategic competitor assessment, market
characterization, opportunities, barriers and challenges in the market along with
SWOT analysis of the PD-1 and PD-L1 inhibitors market
• Pipeline analysis: Comprehensive data split across different phases and
emerging trends and comparative analysis of marketed and pipeline molecules,
pipeline molecules with detailed clinical profiles, mechanism of action, route of
administration and molecule type, along with latest updates

Download
Sample Brochure